Investment
Features
FeesSafety
Academy
More
Pluang+

Psyched Wellness secures $110K loan to fund operations and inventory under AMA brand.

Company Fundamentals
08 Oct 2026
Newsfile Corp
View Source
Neutral
Psyched Wellness secures $110K loan to fund operations and inventory under AMA brand.

Psyched Wellness Ltd. has obtained a secured loan of US$110,577 from Gotham Green Fund I and its affiliate to support operating expenses and inventory purchases for its AMA brand. The loan carries an interest rate of SOFR plus 5% annually, with repayment due by September 9, 2028, and is secured against the company's AMA-related assets. This related party transaction complies with Canadian securities rules and aims to help Psyched Wellness expand its mushroom-derived health product business. The company cautions investors about risks including loan repayment and operational challenges.

Psyched Wellness' recent secured term loan is presented here with a snapshot of the health sector on Pluang. For readers following health stocks, as of Oct 09, 2026 03:21 WIB, out of 128 priced US health-sector stocks, 51 rose and 76 fell. Notable movers include RXRX at USD 3.95 with a 1-day change of -7.49% and a typical hold time of 22 days, HRTX at USD 0.36 down 6.77% with a 35-day hold time, and RVMD at USD 187.99 down 6.41% with a 0-day hold time and 100% buy order activity on Pluang.

More News

SpaceX expands AI infrastructure amid mixed analyst ratings and price targets.

SpaceX expands AI infrastructure amid mixed analyst ratings and price targets.

SpaceX is expanding its AI infrastructure to support its rocket launches, Starlink satellite network, and future AI growth plans. Analysts show mixed but generally positive sentiment, with Morgan Stanley maintaining a Buy rating and a $300 price targ...

Analyst Insights
Bullish
19 minutes ago
Byrna reports Q3 loss despite narrower EPS miss, revenue down 46% amid sales challenges.

Byrna reports Q3 loss despite narrower EPS miss, revenue down 46% amid sales challenges.

Byrna Technologies reported a fiscal Q3 loss of $0.13 per share, better than the expected $0.16 loss, but revenue fell 46% year-over-year to $15.3 million, missing estimates. The company shifted from net income to a $2.9 million net loss due to weake...

Company Fundamentals
Bearish
24 minutes ago
Pacira BioSciences jumps 44% after Viatris agrees to $1.65B acquisition deal

Pacira BioSciences jumps 44% after Viatris agrees to $1.65B acquisition deal

On October 8, 2026, Pacira BioSciences surged 44.4% following Viatris' agreement to acquire the company for $36.50 per share, valuing the deal at approximately $1.65 billion. Other notable gainers included Profound Medical, which rose 21.7% after for...

Market News
Bullish
24 minutes ago
Stocks and leveraged ETFs plunge sharply on October 8, 2026, amid unclear catalysts.

Stocks and leveraged ETFs plunge sharply on October 8, 2026, amid unclear catalysts.

On October 8, 2026, several stocks including AngioDynamics, Apimeds Pharmaceuticals US, and Arqit Quantum experienced steep declines of over 18%, despite some positive financial reports. Leveraged ETFs CRWG and IRE also dropped 15.5%, highlighting th...

Market News
Bearish
24 minutes ago
EU bans authorized crypto providers from offering non-MiCA stablecoins like Tether USDT by Jan 8, 2027

EU bans authorized crypto providers from offering non-MiCA stablecoins like Tether USDT by Jan 8, 2027

The European Securities and Markets Authority (ESMA) issued an opinion on October 8, 2026, requiring EU-authorized crypto service providers to stop offering stablecoins that do not comply with the MiCA regulation, notably Tether's USDT. Providers mus...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App